<DOC>
	<DOCNO>NCT02110108</DOCNO>
	<brief_summary>The purpose study evaluate effect Revlite Laser System treatment facial solar lentigo</brief_summary>
	<brief_title>Study RevLite Laser System Facial Solar Lentigines</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<mesh_term>Lentigo</mesh_term>
	<criteria>1 . Is healthy male female 18 60 year old . 2 . Is Fitzpatrick Skin type IIII 3 . Is willing consent participate study . 4 . Is willing comply requirement study include photograph , follow post treatment care attend treatment follow visit . 5 . Has clinically determine mild severe facial mottle pigmentation ( solar lentigo ) face . 1 . Is female pregnant , pregnant within last 3 month , currently breast feed plan pregnancy study period . 2 . Is hypersensitive light exposure OR take photo sensitized medication . 3 . Has active localize systemic infection . 4 . Has coagulation disorder currently use anticoagulation medication ( include limit heavy use aspirin { great 81 mg per day } ) . 5 . Has condition , investigator 's opinion , would make unsafe subject participate research study . 6 . Is currently enrol investigational drug device trial , receive investigational drug treat investigational device within 3 month prior enter study . 7 . Has use Accutane within 6 month prior enrollment . 8 . Has need expose artificial tanning device excessive sunlight trial . 9 . Has prior treatment parenteral gold therapy ( gold sodium thiomalate ) . 10 . Has history keloid . 11 . Has evidence compromise wound heal . 12 . Has history basal cell carcinoma , squamous cell carcinoma melanoma . 13 . Has history immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) use immunosuppressive medication autoimmune disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>